Skip to main content
Log in

Evaluation of insulin sensitivity in hyperprolactinemic subjects by euglycemic hyperinsulinemic clamp technique

  • Published:
Pituitary Aims and scope Submit manuscript

Abstract

The background and aim of the study is to evaluate insulin sensitivity in hyperprolactinemic subjects via euglycemic hyperinsulinemic clamp technique. Sixteen hyperprolactinemic subjects and 12 healthy subjects were included in the study. HOMA-B and HOMA-IR values of groups were calculated. Euglycemic hyperinsulinemic clamp technique was performed in both groups, and the M value of the groups was defined. Mann–Whitney U and chi-square tests were used in statistical analysis. Basal insulin level of hyperprolactinemic patients were higher than the control group (6.85 ± 4.68; 3.66 ± 0.88 μU/ml respectively; P < 0.05). Mean HOMA-IR and HOMA-B values of patients were higher than control group (1.49 ± 1.30; 0.78 ± 0.27 respectively; P = 0.02 and 136.28 ± 72.53; 64.77 ± 23.31, respectively, P < 0.001). M values of the patients were statistically lower than the control group (5.64 ± 2.36; 7.05 ± 1.62 kg/mg/min respectively; P < 0.05). (1) Hyperprolactinemic patients were more insulin resistant than control subjects. (2) Insulin resistance in hyperprolactinemic patients is not associated with obesity or anthropometric parameters such as fat content, waist circumference and BMI.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Baptista T et al (2004) Comparative effects of the antipsychotics sulpiride and risperidone in female rats on energy balance, body composition, fat morphology and macronutrient selection. Prog Neuropsychopharmacol Biol Psychiatry 28:1305–1311. doi:10.1016/j.pnpbp.2004.08.001

    Article  CAS  PubMed  Google Scholar 

  2. Knudtzon J, Johansen PW, Haug E, Gautvik K (1986) Effects of hypersecretion of growth hormone and prolactin on plasma levels of glucagon and insulin in GH3-celltumor-bearing rats, and the influence of bromocriptine treatment. Life Sci 39:617–621. doi:10.1016/0024-3205(86)90042-1

    Article  CAS  PubMed  Google Scholar 

  3. Byatt JC, Staten NR, Salsgiver WJ, Kostelc JG, Collier RJ (1993) Stimulation of food intake and weight gain in mature female rats by bovine prolactin and bovine growth hormone. Am J Physiol 264:E986–E992

    CAS  PubMed  Google Scholar 

  4. Moore BJ, Gerardo-Gettens T, Horwitz BA, Stern JS (1986) Hyperprolactinemia stimulates food intake in the female rat. Brain Res Bull 17:563–569. doi:10.1016/0361-9230(86)90226-1

    Article  CAS  PubMed  Google Scholar 

  5. Baptista T, Lacruz A, de Mendoza S, Mendoza Guillén JM, Silvera R, Angeles F, Mendoza MT, Hernández L (2000) Body weight gain after administration of antipsychotic drugs: correlation with leptin, insulin and reproductive hormones. Pharmacopsychiatry 33:81–88. doi:10.1055/s-2000-8451

    Article  CAS  PubMed  Google Scholar 

  6. Doknic M, Pekic S, Zarkovic M, Medic-Stojanoska M, Dieguez C, Casanueva F, Popovic V (2002) Dopaminergic tone and obesity: an insight from prolactinomas treated with bromocriptine. Eur J Endocrinol 147:77–84. doi:10.1530/eje.0.1470077

    Article  CAS  PubMed  Google Scholar 

  7. Greenman Y, Tordjman K, Stern N (1998) Increased body weight associated with prolactin secreting pituitary adenomas: weight loss with normalization of prolactin levels. Clin Endocrinol (Oxf) 48:547–553. doi:10.1046/j.1365-2265.1998.00403.x

    Article  CAS  Google Scholar 

  8. Brandebourg T, Hugo E, Ben-Jonathan N (2007) Adipocyte prolactin: regulation of release and putative functions. Diabetes Obes Metab 9(4):464–476. doi:10.1111/j.1463-1326.2006.00671.x

    Article  CAS  PubMed  Google Scholar 

  9. Serri O, Beauregard H, Rasio E, Hardy J (1986) Decreased sensitivity to insulin in women with microprolactinomas. Fertil Steril 45:572–574

    CAS  PubMed  Google Scholar 

  10. Gustafson AB, Banasiak MF, Kalkhoff RK, Hagen TC, Kim HJ (1980) Correlation of hyperprolactinemia with altered plasma insulin and glucagon: similarity to effects of late human pregnancy. J Clin Endocrinol Metab 51:242–246

    Article  CAS  PubMed  Google Scholar 

  11. Schernthaner G, Prager R, Punzengruber C, Luger A (1985) Severe hyperprolactinemia is associated with decreased insulin binding in vitro and insulin resistance in vivo. Diabetologia 28:138–142

    CAS  PubMed  Google Scholar 

  12. Bahceci M, Tuzcu A, Bahceci S, Tuzcu S (2003) Is hyperprolactinemia associated with insulin resistance in non-obese patients with polycystic ovary syndrome? J Endocrinol Invest 26(7):655–659

    CAS  PubMed  Google Scholar 

  13. Tuzcu A, Bahceci M, Dursun M, Turgut C, Bahceci S (2003) Insulin sensitivity and hyperprolactinemia. J Endocrinol Invest 26(4):341–346

    CAS  PubMed  Google Scholar 

  14. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18(6):499–502

    CAS  PubMed  Google Scholar 

  15. De Fronzo RA, Tobin JD, Andres R (1979) Glucose clamp tecnique: a method for quantifying insulin secretation and resistance. Am J Physiol 237:E214–E223

    Google Scholar 

  16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419. doi:10.1007/BF00280883

    Article  CAS  PubMed  Google Scholar 

  17. Wallace TM, Levy JC, Matthews DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27:1487–1495. doi:10.2337/diacare.27.6.1487

    Article  PubMed  Google Scholar 

  18. Pelkonen R, Nikkilä EA, Grahne B (1982) Serum lipids, postheparin plasma lipase activities and glucose tolerance in patients with prolactinoma. Clin Endocrinol (Oxf) 16:383–390

    Article  CAS  Google Scholar 

  19. Foss MC, Paula FJ, Paccola GM, Piccinato CE (1995) Peripheral glucose metabolism in human hyperprolactinemia. Clin Endocrinol (Oxf) 43:721–726

    Article  CAS  Google Scholar 

  20. Reis FM, Reis AM, Coimbra CC (1997) Effects of hyperprolactinaemia on glucose tolerance and insulin release in male and female rats. J Endocrinol 153(3):423–428. doi:10.1677/joe.0.1530423

    Article  CAS  PubMed  Google Scholar 

  21. Serri O, Ling L, Mamputu JC, Beauchamp MC, Maingrette F, Renier G (2006) The influences of hyperprolactinemia and obesity on cardiovascular risk markers: effects of cabergoline therapy. Clin Endocrinol (Oxf) 64:366–370

    CAS  Google Scholar 

  22. Cincotta AH, Meier AH, Cincotta M Jr (1999) Bromocriptine improves glycaemic control and serum lipid profile in obese Type 2 diabetic subjects: a new approach in the treatment of diabetes. Expert Opin Investig Drugs 8(10):1683–1707

    Article  CAS  PubMed  Google Scholar 

  23. Baptista T, Lacruz A, Meza T et al (2001) Antipsychotic drugs and obesity: is prolactin involved? Can J Psychiatry 46:829–834

    CAS  PubMed  Google Scholar 

  24. Creemers LB, Zelissen PM, van’t Verlaat JW, Koppeschaar HP (1991) Prolactinoma and body weight: a retrospective study. Acta Endocrinol (Copenh) 125:392–396

    CAS  Google Scholar 

  25. Kok P, Roelfsema F, Frölich M, Meinders E, Pijl H (2004) Prolactin release is enhanced in proportion to excess visceral fat in obese women. J Clin Endocrinol Metab 89:4445–4449

    Article  CAS  PubMed  Google Scholar 

  26. Schmid C, Goede DL, Hauser RS, Brändle M (2006) Increased prevalence of high body mass index in patients presenting with pituitary tumours: severe obesity in patients with macroprolactinoma. Swiss Med Wkly 138:254–258

    Google Scholar 

  27. Asai-Sato M, Okamoto M, Endo M et al (2006) Hypoadiponectinemmia in lean lactating women: prolactin inhibits adiponectin secretion from human adipocytes. Endocr J 53:555–562

    Article  CAS  PubMed  Google Scholar 

  28. Nilsson L, Binart N, Bohlooly YM et al (2005) Prolactin and growth hormone regulate adiponectin secretion and receptor expression in adipose tissue. Biochem Biophys Res Commun 331:1120–1126

    Article  CAS  PubMed  Google Scholar 

  29. Fuglsang J, Skjærbæk C, Frystyk J, Flyvbjerg A, Ovesen P (2006) A longitudinal study of serum adiponectin during normal pregnancy. BJOG 113(1):110–113. doi:10.1111/j.1471-0528.2005.00792.x

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alpaslan Tuzcu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tuzcu, A., Yalaki, S., Arikan, S. et al. Evaluation of insulin sensitivity in hyperprolactinemic subjects by euglycemic hyperinsulinemic clamp technique. Pituitary 12, 330–334 (2009). https://doi.org/10.1007/s11102-009-0183-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11102-009-0183-1

Keywords

Navigation